A diagnosis of an NMO spectrum disorder (NMOSD) can be made in ON after one episode in the case of AQP4-Ab seropositivity, which indicates worse visual outcomes, a high recurrence rate, and the need for early immunosuppressive therapy as NMO differs from MS (4). Here, AQP4 is linked to neuromyelitis optica.